Obsidian Therapeutics files prospectus for resale of up to 29,164,045 shares
Obsidian Therapeutics filed a prospectus covering the resale of up to 29,164,045 shares of common stock by selling stockholders.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.